At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Sorted Descending Type Shares Traded Price Range
Oct 17, 2008 bloch stephen m Director Automatic Sell 3,000 10.75
Oct 20, 2008 bloch stephen m Director Automatic Sell 3,000 10.59
Jul 11, 2008 bloch stephen m Director Automatic Sell 8,893 12.55
Jul 14, 2008 bloch stephen m Director Automatic Sell 1,600 12.61
Jul 15, 2008 bloch stephen m Director Automatic Sell 5,600 12.90
Jul 28, 2008 bloch stephen m Director Automatic Sell 9,000 15.23
Jul 29, 2008 bloch stephen m Director Automatic Sell 3,600 15.30
Jul 30, 2008 bloch stephen m Director Automatic Sell 4,700 15.19
Jul 31, 2008 bloch stephen m Director Automatic Sell 10,000 15.47 - 15465.00
Aug 1, 2008 bloch stephen m Director Automatic Sell 3,700 15.45
Aug 4, 2008 bloch stephen m Director Automatic Sell 4,500 15.23
Jul 22, 2008 bloch stephen m Director Automatic Sell 8,589 15.01
Jul 23, 2008 bloch stephen m Director Automatic Sell 1,834 15.00
Jul 24, 2008 bloch stephen m Director Automatic Sell 5,661 15.24
Jul 25, 2008 bloch stephen m Director Automatic Sell 2,300 15.43
Jul 16, 2008 bloch stephen m Director Automatic Sell 1,900 13.16
Jul 17, 2008 bloch stephen m Director Automatic Sell 1,600 13.38
Jul 18, 2008 bloch stephen m Director Automatic Sell 10,400 13.86
Jul 21, 2008 bloch stephen m Director Automatic Sell 7,600 14.47
Jun 5, 2007 neff p sherrill Director Acquisition (Non Open Market) 1,419,762 n/a
Showing 221-240 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy